Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Activated oncogenes in human tumors].

T Noguchi1, J Adelaide, I Marics

  • 1Unité 119 de l'INSERM, Marseille, France.

Bulletin Du Cancer
|January 1, 1987
PubMed
Summary

Ras oncogenes, altered by point mutation in human cancers, contribute to malignancy, likely with other oncogenes. This review details ras genes, activating mutations, and protein properties in cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study.

Blood cancer journal·2020
Same author

Publisher Correction: SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations.

Nature structural & molecular biology·2020
Same author

Author Correction: SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations.

Nature structural & molecular biology·2020
Same author

SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations.

Nature structural & molecular biology·2020
Same author

Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2020
Same author

Pathological grade-independent prediction of chemosensitivity by CINSARC should rehabilitate adjuvant chemotherapy in soft tissue sarcomas of any grade.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Context:

  • Ras oncogenes are frequently mutated in human cancers.
  • These mutations are crucial for malignant transformation.
  • Ras proteins are key regulators of cellular processes.

Purpose:

  • To describe the ras genes implicated in human cancers.
  • To detail the specific point mutations that activate ras genes.
  • To outline the functional properties of activated ras proteins.

Summary:

  • Ras oncogenes are cellular genes that undergo point mutations in 10-30% of human tumors.
  • Mutated ras oncogenes play a significant role in cancer development, potentially interacting with other oncogenes.
  • The review covers identified ras genes in human cancers, the activating point mutations, and the characteristics of the resulting ras proteins.

Related Experiment Videos

Impact:

  • Provides a comprehensive overview of ras oncogenes in cancer.
  • Highlights the molecular mechanisms underlying ras-driven tumorigenesis.
  • Serves as a foundational resource for researchers studying ras in oncology.